Organization
Impact Biotech
2 clinical trials
1 abstract
Clinical trial
A Multicenter Open-label Phase 1 Trial to Evaluate Safety and Preliminary Efficacy of Endovascularly Applied Vascular Targeted Photodynamic Therapy (VTP) for Patients With Locally Advanced Unresectable Pancreatic Ductal AdenocarcinomaStatus: Not yet recruiting, Estimated PCD: 2025-04-30
Clinical trial
A Multicenter Open-label Phase 1/1b Study to Evaluate Safety, Feasibility and Early Treatment Effect of Padeliporfin VTP Using Robotic Assisted Bronchoscopy and Cone Beam CT Guidance in Patients With Peripheral Lung CancerStatus: Not yet recruiting, Estimated PCD: 2026-05-30
Abstract
A phase 3 multicenter study to evaluate the safety and efficacy of padeliporfin vascular targeted photodynamic therapy (VTP) in treatment of low-grade (LG) upper tract urothelial cancer (UTUC).Org: Memorial Sloan Kettering Cancer Center, University of Texas Southwestern Medical Center, Weizmann Institute of Science, Steba Biotech, Impact Biotech,